UPDATED May 21, 2024
Companies with a Value score of at least 3, ordered by Value score
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
0MUF | €13.13 | 0% | 2.2% | €100.4m | €22.72 | PE22.7x | E25.7% | 0.3% | Software | ||
OMUL | R0.48 | -1.0% | 3.2% | R48.1b | n/a | PE6.8x | E6.8% | 7.3% | Insurance | ||
MONYL | UK£2.36 | 2.1% | -9.6% | UK£1.3b | UK£2.90 | PE17.5x | E10.5% | 5.1% | Media | ||
BCOD | US$172.86 | 2.8% | n/a | US$113.4b | US$210.45 | PS1.5x | E53.9% | 0% | Capital Goods | ||
0J9O | €7.36 | -6.8% | -65.3% | €63.0m | €13.33 | PB0.6x | E123.4% | n/a | Semiconductors | ||
0RHI | €25.06 | -6.9% | 0.05% | €3.2b | €33.70 | PE14.3x | E16.9% | 6.2% | Capital Goods | ||
0IX0 | €20.30 | 1.5% | -3.8% | €593.8m | €24.89 | PE9.9x | E8.6% | 3.4% | Commercial Services | ||
0QCO | €0.82 | -4.7% | -30.5% | €548.5m | €1.94 | PS2.3x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
0Q8F | €50.02 | 2.4% | -23.2% | €3.5b | €68.08 | PE13.2x | E12.7% | 2.7% | Consumer Durables | ||
0JWC | US$40.89 | -0.9% | 2.7% | US$12.8b | US$56.51 | PE14.3x | E7.7% | 0% | Consumer Services | ||
0NW1 | €11.14 | -6.5% | -29.1% | €1.6b | €14.01 | PE9.9x | E18.1% | 3.5% | Automobiles | ||
SNR | UK£1.68 | -1.3% | -2.1% | UK£685.2m | UK£2.10 | PE22x | E23.3% | 1.4% | Capital Goods | ||
0L49 | US$2.65 | 18.8% | -4.3% | US$100.9m | US$6.82 | PE1x | E-12.3% | n/a | Pharmaceuticals & Biotech | ||
0MN5 | €36.55 | 0.2% | -8.2% | €344.6m | €45.21 | PE15.1x | E10.9% | 4.6% | Software | ||
0N9Z | €29.70 | -10.3% | 35.6% | €405.0m | €39.07 | PE11x | E2.9% | 3.6% | Tech | ||
0RFW | €3.52 | -3.0% | -11.5% | €528.9m | €6.65 | PE12.4x | E13.4% | 2.8% | Software | ||
CLNZ | CHF10.87 | -2.8% | -28.9% | CHF3.6b | CHF15.00 | PB1.5x | E42.8% | 3.9% | Materials | ||
DSMA | €114.50 | 0% | -27.2% | €763.7m | €149.84 | PE1.7x | E20.5% | 2.2% | Materials | ||
CAPDL | UK£1.01 | 2.9% | 4.3% | UK£197.2m | UK£1.49 | PE6.8x | E-0.5% | 3.1% | Materials | ||
ASCNZ | CHF7.89 | -1.6% | -13.2% | CHF285.2m | CHF12.09 | PE16.4x | E12.9% | 3.8% | Healthcare | ||
SANP | €90.16 | -1.9% | -10.3% | €112.5b | €108.52 | PE24.8x | E16.9% | 4.2% | Pharmaceuticals & Biotech | ||
DCCL | UK£58.50 | -1.5% | 20.3% | UK£5.8b | UK£70.71 | PE17.7x | E10.2% | 3.4% | Capital Goods | ||
0O59 | €90.00 | -0.6% | -10.8% | €112.5b | €108.34 | PE24.8x | E16.9% | 4.2% | Pharmaceuticals & Biotech | ||
JET2 | UK£13.38 | -1.6% | 12.8% | UK£2.9b | UK£19.14 | PE6.7x | E1.1% | 0.9% | Transportation |